Monday, September 24, 2018 11:56:17 PM
Sept 18
“As we continue to make significant progress commercializing and scaling production of our existing recombinant spider silk offerings,"
Again there is room for the truth of it going either way. They start to talk about providing an update on prodigy, then start a new paragraph saying they are making significant progress scaling production. BUT then you add word from one of the usual great DD peeps(crazy good DD) here, and it says when they are ready to open Prodigy, they are open for business. That is the way it sounds to me, and it may not mean we have to wait for good numbers months away from the open.
When Kim decides to announce is the thing. I could see him waiting for proof of every step. The way Quang Nam is starting to talk, and everything I am hearing means good things.
All this said, I have been here before and we had the carpet pulled out from production overseas before. Nothing happens until it is officially announced. Kim is thorough enough to frustrate and make us wait 2 more months. You could probably add more time for any number of reasons I am unaware of. Is there official morning for the loss of their President? I suppose "in the near future" can be twisted into taking months. Still I am cautiously optimistic, but it often is not just a matter of reading PR's. Again, we'll see what aggressive and significant means....Not the time for hyperbole.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM